| Bridgetown Nursing And Rehabilitation Centre | |
| 4307 Bridgetown Road, Cheviot, Ohio 45211 | |
| (513) 598-8000 | |
| Name | Bridgetown Nursing And Rehabilitation Centre |
|---|---|
| Location | 4307 Bridgetown Road, Cheviot, Ohio |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 70 |
| Occupancy Rate | 59.29% |
| Medicare ID (CCN) | 365462 |
| Legal Business Name | Bridgetown Health Care Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1083999445 |
| Organization Name | GENESIS REHAB SERVICES |
| Address | 4307 Bridgetown Rd, Cincinnati, OH 45211 |
| Phone Number | 513-598-8000 |
News Archive
Diagnosing Chronic Traumatic Encephalopathy (CTE) during life is crucial for developing therapies and for determining how common the disease is among individuals exposed to repetitive head impacts from contact sports, military service and physical violence.
A multinational clinical trial led by UT Southwestern Medical Center and others found that injection of a new long-acting insulin combined with another drug improves glucose control in patients with Type 2 diabetes and, additionally, is associated with weight loss.
CombinatoRx, Incorporated today announced that it has received a milestone payment from Fovea Pharmaceuticals, a division of Sanofi Aventis, relating to Fovea's initiation of Phase 2b clinical testing of PrednisporinTM (FOV1101) in subjects with persistent allergic conjunctivitis. Prednisporin™ is a CombinatoRx-derived combination drug candidate that was exclusively licensed to Fovea by CombinatoRx.
As preparations for the launch of SMOS and Proba-2 continue on schedule, the engineers and technicians at the Russian launch site say goodbye as both satellites are encapsulated within the half-shells of the Rockot fairing.
› Verified 8 days ago
| NPI Number | 1336701242 |
| Organization Name | BRIDGETOWN HEALTH CARE LLC |
| Address | 4307 Bridgetown Rd, Cincinnati, OH 45211 |
| Phone Number | 513-598-8000 |
News Archive
Diagnosing Chronic Traumatic Encephalopathy (CTE) during life is crucial for developing therapies and for determining how common the disease is among individuals exposed to repetitive head impacts from contact sports, military service and physical violence.
A multinational clinical trial led by UT Southwestern Medical Center and others found that injection of a new long-acting insulin combined with another drug improves glucose control in patients with Type 2 diabetes and, additionally, is associated with weight loss.
CombinatoRx, Incorporated today announced that it has received a milestone payment from Fovea Pharmaceuticals, a division of Sanofi Aventis, relating to Fovea's initiation of Phase 2b clinical testing of PrednisporinTM (FOV1101) in subjects with persistent allergic conjunctivitis. Prednisporin™ is a CombinatoRx-derived combination drug candidate that was exclusively licensed to Fovea by CombinatoRx.
As preparations for the launch of SMOS and Proba-2 continue on schedule, the engineers and technicians at the Russian launch site say goodbye as both satellites are encapsulated within the half-shells of the Rockot fairing.
› Verified 8 days ago
| NPI Number | 1447556386 |
| Organization Name | OAKTREE LLC |
| Doing Business As | OAK HILLS NURSING AND REHAB |
| Address | 4307 Bridgetown Rd, Cincinnati, OH 45211 |
| Phone Number | 513-377-1512 |
News Archive
Diagnosing Chronic Traumatic Encephalopathy (CTE) during life is crucial for developing therapies and for determining how common the disease is among individuals exposed to repetitive head impacts from contact sports, military service and physical violence.
A multinational clinical trial led by UT Southwestern Medical Center and others found that injection of a new long-acting insulin combined with another drug improves glucose control in patients with Type 2 diabetes and, additionally, is associated with weight loss.
CombinatoRx, Incorporated today announced that it has received a milestone payment from Fovea Pharmaceuticals, a division of Sanofi Aventis, relating to Fovea's initiation of Phase 2b clinical testing of PrednisporinTM (FOV1101) in subjects with persistent allergic conjunctivitis. Prednisporin™ is a CombinatoRx-derived combination drug candidate that was exclusively licensed to Fovea by CombinatoRx.
As preparations for the launch of SMOS and Proba-2 continue on schedule, the engineers and technicians at the Russian launch site say goodbye as both satellites are encapsulated within the half-shells of the Rockot fairing.
› Verified 8 days ago
| NPI Number | 1518151729 |
| Organization Name | MOSKOWITZ FAMILY V |
| Doing Business As | OAK HILLS PAVILION |
| Address | 4307 Bridgetown Rd, Cincinnati, OH 45211 |
| Phone Number | 513-598-8000 |
News Archive
Diagnosing Chronic Traumatic Encephalopathy (CTE) during life is crucial for developing therapies and for determining how common the disease is among individuals exposed to repetitive head impacts from contact sports, military service and physical violence.
A multinational clinical trial led by UT Southwestern Medical Center and others found that injection of a new long-acting insulin combined with another drug improves glucose control in patients with Type 2 diabetes and, additionally, is associated with weight loss.
CombinatoRx, Incorporated today announced that it has received a milestone payment from Fovea Pharmaceuticals, a division of Sanofi Aventis, relating to Fovea's initiation of Phase 2b clinical testing of PrednisporinTM (FOV1101) in subjects with persistent allergic conjunctivitis. Prednisporin™ is a CombinatoRx-derived combination drug candidate that was exclusively licensed to Fovea by CombinatoRx.
As preparations for the launch of SMOS and Proba-2 continue on schedule, the engineers and technicians at the Russian launch site say goodbye as both satellites are encapsulated within the half-shells of the Rockot fairing.
› Verified 8 days ago
| NPI Number | 1639436850 |
| Organization Name | GENESIS REHABILITATION SERVICES |
| Address | 4307 Bridgetown Rd, Cincinnati, OH 45211 |
| Phone Number | 513-598-8000 |
News Archive
Diagnosing Chronic Traumatic Encephalopathy (CTE) during life is crucial for developing therapies and for determining how common the disease is among individuals exposed to repetitive head impacts from contact sports, military service and physical violence.
A multinational clinical trial led by UT Southwestern Medical Center and others found that injection of a new long-acting insulin combined with another drug improves glucose control in patients with Type 2 diabetes and, additionally, is associated with weight loss.
CombinatoRx, Incorporated today announced that it has received a milestone payment from Fovea Pharmaceuticals, a division of Sanofi Aventis, relating to Fovea's initiation of Phase 2b clinical testing of PrednisporinTM (FOV1101) in subjects with persistent allergic conjunctivitis. Prednisporin™ is a CombinatoRx-derived combination drug candidate that was exclusively licensed to Fovea by CombinatoRx.
As preparations for the launch of SMOS and Proba-2 continue on schedule, the engineers and technicians at the Russian launch site say goodbye as both satellites are encapsulated within the half-shells of the Rockot fairing.
› Verified 8 days ago
| NPI Number | 1720437254 |
| Organization Name | OAK WOOD I LLC |
| Doing Business As | OAK RIDGE POST ACUTE CARE |
| Address | 3889 E Galbraith Rd, Cincinnati, OH 45236 |
| Phone Number | 786-564-9339 |
News Archive
Diagnosing Chronic Traumatic Encephalopathy (CTE) during life is crucial for developing therapies and for determining how common the disease is among individuals exposed to repetitive head impacts from contact sports, military service and physical violence.
A multinational clinical trial led by UT Southwestern Medical Center and others found that injection of a new long-acting insulin combined with another drug improves glucose control in patients with Type 2 diabetes and, additionally, is associated with weight loss.
CombinatoRx, Incorporated today announced that it has received a milestone payment from Fovea Pharmaceuticals, a division of Sanofi Aventis, relating to Fovea's initiation of Phase 2b clinical testing of PrednisporinTM (FOV1101) in subjects with persistent allergic conjunctivitis. Prednisporin™ is a CombinatoRx-derived combination drug candidate that was exclusively licensed to Fovea by CombinatoRx.
As preparations for the launch of SMOS and Proba-2 continue on schedule, the engineers and technicians at the Russian launch site say goodbye as both satellites are encapsulated within the half-shells of the Rockot fairing.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Diagnosing Chronic Traumatic Encephalopathy (CTE) during life is crucial for developing therapies and for determining how common the disease is among individuals exposed to repetitive head impacts from contact sports, military service and physical violence.
A multinational clinical trial led by UT Southwestern Medical Center and others found that injection of a new long-acting insulin combined with another drug improves glucose control in patients with Type 2 diabetes and, additionally, is associated with weight loss.
CombinatoRx, Incorporated today announced that it has received a milestone payment from Fovea Pharmaceuticals, a division of Sanofi Aventis, relating to Fovea's initiation of Phase 2b clinical testing of PrednisporinTM (FOV1101) in subjects with persistent allergic conjunctivitis. Prednisporin™ is a CombinatoRx-derived combination drug candidate that was exclusively licensed to Fovea by CombinatoRx.
As preparations for the launch of SMOS and Proba-2 continue on schedule, the engineers and technicians at the Russian launch site say goodbye as both satellites are encapsulated within the half-shells of the Rockot fairing.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 29.49 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 1.95 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 24.14 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.97 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.24 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.66 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.22 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 20.28 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 91.35 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 6.6 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 28.66 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 0 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 91.98 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 40.25 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 88.67 | 82.93 |
News Archive
Diagnosing Chronic Traumatic Encephalopathy (CTE) during life is crucial for developing therapies and for determining how common the disease is among individuals exposed to repetitive head impacts from contact sports, military service and physical violence.
A multinational clinical trial led by UT Southwestern Medical Center and others found that injection of a new long-acting insulin combined with another drug improves glucose control in patients with Type 2 diabetes and, additionally, is associated with weight loss.
CombinatoRx, Incorporated today announced that it has received a milestone payment from Fovea Pharmaceuticals, a division of Sanofi Aventis, relating to Fovea's initiation of Phase 2b clinical testing of PrednisporinTM (FOV1101) in subjects with persistent allergic conjunctivitis. Prednisporin™ is a CombinatoRx-derived combination drug candidate that was exclusively licensed to Fovea by CombinatoRx.
As preparations for the launch of SMOS and Proba-2 continue on schedule, the engineers and technicians at the Russian launch site say goodbye as both satellites are encapsulated within the half-shells of the Rockot fairing.
› Verified 8 days ago
Bridgetown Nursing And Rehabilitation Centre Location: 4307 Bridgetown Road, Cheviot, Ohio 45211 Phone: (513) 598-8000 |